These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17122996)

  • 1. Reconstituted botulinum type A neurotoxin: clinical efficacy after long-term freezing before use.
    Parsa AA; Lye KD; Parsa FD
    Aesthetic Plast Surg; 2007; 31(2):188-91; discussion 192-3. PubMed ID: 17122996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of repeated intradetrusor botulinum neurotoxin A injections on detrusor function in patients with neurogenic bladder dysfunction.
    Pannek J; Göcking K; Bersch U
    BJU Int; 2009 Nov; 104(9):1246-50. PubMed ID: 19426192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
    Rubin MG; Dover J; Glogau RG; Goldberg DJ; Goldman MP; Schlessinger J
    J Drugs Dermatol; 2009 May; 8(5):439-44. PubMed ID: 19537366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blind multicenter study of the efficacy and safety of injections of a commercial preparation of botulinum toxin type A reconstituted up to 15 days before injection.
    Hexsel D; Rutowitsch MS; de Castro LC; do Prado DZ; Lima MM
    Dermatol Surg; 2009 Jun; 35(6):933-9; discussion 940. PubMed ID: 19397645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of botulinum neurotoxin serotype A: a cosmetic perspective.
    Eapen BR
    J Cosmet Dermatol; 2008 Sep; 7(3):221-5. PubMed ID: 18789058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study.
    Miller D; Richardson D; Eisa M; Bajwa RJ; Jabbari B
    Pain Med; 2009 Sep; 10(6):1012-7. PubMed ID: 19594841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated botulinum toxin A injections for the treatment of lines in the upper face: a retrospective study of 4,103 treatments in 945 patients.
    Rzany B; Dill-Müller D; Grablowitz D; Heckmann M; Caird D;
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S18-25. PubMed ID: 17241409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of botulinum toxin type A reconstituted and refrigerated 1 week before its application in external canthus dynamic lines.
    Lizarralde M; Gutiérrez SH; Venegas A
    Dermatol Surg; 2007 Nov; 33(11):1328-33; discussion 1333. PubMed ID: 17958584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait.
    Nagarajan V; Al-Shubaili A; Ayad YM; Alexander J; Al-Ramezi K
    Med Princ Pract; 2007; 16(3):181-6. PubMed ID: 17409751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome.
    Kuo HC; Chancellor MB
    BJU Int; 2009 Sep; 104(5):657-61. PubMed ID: 19338543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose subcutaneous injection of botulinum toxin type A for facial synkinesis and hyperlacrimation.
    Ito H; Ito H; Nakano S; Kusaka H
    Acta Neurol Scand; 2007 Apr; 115(4):271-4. PubMed ID: 17376126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on craniofacial growth and development of unilateral botulinum neurotoxin injection into the masseter muscle.
    Tsai CY; Chiu WC; Liao YH; Tsai CM
    Am J Orthod Dentofacial Orthop; 2009 Feb; 135(2):142.e1-6; discussion 142-3. PubMed ID: 19201315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupivacaine-induced myotoxicity and its effect on botulinum toxin paresis.
    Yen MT; Wall VK
    Ann Plast Surg; 2008 Jan; 60(1):6-9. PubMed ID: 18281786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup.
    Giannantoni A; Porena M; Costantini E; Zucchi A; Mearini L; Mearini E
    J Urol; 2008 Mar; 179(3):1031-4. PubMed ID: 18206941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic satisfaction and dissatisfaction in patients with spinal cord lesions and detrusor sphincter dyssynergia who received detrusor botulinum toxin a injection.
    Kuo HC
    Urology; 2008 Nov; 72(5):1056-60. PubMed ID: 18533231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for recurrent anal fissure following lateral internal sphincterotomy.
    Brisinda G; Cadeddu F; Brandara F; Marniga G; Vanella S; Nigro C; Maria G
    Br J Surg; 2008 Jun; 95(6):774-8. PubMed ID: 18425796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.
    Jeffery S; Fynes M; Lee F; Wang K; Williams L; Morley R
    BJU Int; 2007 Dec; 100(6):1302-6. PubMed ID: 17979928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.